Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
AMANTA
₹205.20
₹196.76
₹205.57
₹92.00
₹195.83
Markets Today
Historical Performance
As of 25-08-2026 02:02, Amanta Healthcare Ltd. share price today is ₹0, with a change of ₹-195.79 (-100.00%) from the previous close of ₹195.79. The stock opened at ₹198.7 and traded between ₹196.76 and ₹205.57, with a total traded volume of 261042 shares. The company has a market capitalization of ₹760.2 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹195.83 and ₹92, respectively.
Amanta Healthcare Ltd. valuation metrics include a P/E ratio of 51.8, and book value of ₹3.40. Profitability indicators show ROE of 6.75%. Amanta Healthcare Ltd. has reported revenue of ₹291.17 Cr and net profit of ₹14.68 Cr.
Amanta Healthcare Ltd. technical indicators include Day RSI at 72.8, Day MFI at 93.56, Day ADX at 20.67. Additional indicators include Commodity Channel Index (CCI) at 242.8 and Williams %R at -0.09. Momentum indicators show Day MACD at 4.54, Day MACD Signal Line at 1.6, DayATR at 6.91. Rate of Change indicators for Amanta Healthcare Ltd. include ROC125 at 80.63 and ROC21 at 17.95.
Exponential moving averages include EMA5 at ₹181.7, EMA10 at ₹174.5, EMA12 at ₹173.1, EMA20 at ₹170.1, EMA26 at ₹168.6, EMA50 at ₹162.2, EMA100 at ₹150.3, EMA200 at ₹135.1. Simple moving averages include SMA5 at ₹179.3, SMA10 at ₹168.5, SMA20 at ₹167.5, SMA30 at ₹167.6, SMA50 at ₹165.8, SMA100 at ₹146.4, SMA150 at ₹131.7, SMA200 at ₹126.6.
Support levels for Amanta Healthcare are placed at First Support ₹189.25, Second Support ₹182.71, Third Support ₹179.42. Resistance levels are seen at First Resistance ₹199.08, Second Resistance ₹202.37, Third Resistance ₹208.91. Amanta Healthcare Ltd. shareholding pattern shows promoter holding at 63.8%, FII holding at 0.43%, DII holding at 0%, public holding at 22.84%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 68.80 | 76.99 | 74.49 | 70.89 | 65.31 |
| Operating Expense | 54.26 | 62.04 | 59.13 | 56.24 | 50.41 |
| Operating Profit | 14.54 | 14.95 | 15.36 | 14.65 | 14.89 |
| Depreciation | 4.69 | 4.75 | 4.67 | 4.66 | 4.64 |
| Interest | 6 | 4.25 | 5.06 | 5.15 | 6.29 |
| Tax | 1.18 | 2.09 | 1.67 | 1.07 | 1.42 |
| Net Profit | 3.31 | 5.53 | 4.63 | 1.21 | 3.51 |
₹205.20
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Promoter | 63.6 | 63.6 | 63.7 | 63.8 |
| FII | 1 | 1.1 | 0.8 | 0.4 |
| DII | 11.3 | 11.2 | 12.9 | 13 |
| Public | 24.1 | 24.1 | 22.6 | 22.8 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 2.77 L | 2.77 L | 100.00% |
| Week | 2.78 L | 2.78 L | 100.00% |
| 1 Month | 91.48 K | 91.48 K | 100.00% |
| 6 Month | 1.08 L | 2.06 L | 52.38% |
Benjamin Graham Value Screen
Strong Performer, Getting Expensive (DVM)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Consistent high performing stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over 1 Year
Stocks whose current price is 20% higher than week low, and more than previous close
Stringent DVM Screener
Weekly Screener: High Momentum Score Stocks (subscription)
Annual Profit Growth higher than Sector Profit Growth
Stocks gaining versus previous close, open price and RSI
New 52 week high today
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Highest Recovery from 52 Week Low
RSI indicating price strength
Top Gainers
New 52 Week High
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹526.25 | ₹6.55 | ₹15.46 | ₹518.70 | ₹100.52 |
| % Change | -2.70% | 4.97% | 8.26% | -3.29% | 4.99% |
| Revenue TTM (₹ Cr) | ₹526.28 | ₹69.99 | ₹226.23 | ₹511.48 | ₹305.93 |
| Net Profit TTM (₹ Cr) | ₹20.77 | ₹-176.47 | ₹31.63 | ₹53.97 | ₹16.01 |
| PE TTM | 115.10 | -0.30 | 2.40 | 28.70 | 32.50 |
| 1 Year Return | 37.97 | 524 | 56.92 | -23.59 | 8.81 |
| ROCE | 3.56 | -56.37 | 17.36 | 23.87 | 0.77 |
Sigachi Industries Ltd.
₹ 30.45
+1.33%
Windlas Biotech Ltd.
₹ 988.00
-0.56%
Vineet Laboratories Ltd.
₹ 37.00
-2.14%
Solara Active Pharma Sciences Ltd.
₹ 628.00
+1.80%
Zim Laboratories Ltd.
₹ 124.16
-0.70%
Medico Remedies Ltd.
₹ 42.09
-1.31%
Dishman Carbogen Amcis Ltd.
₹ 173.00
-0.31%
Lasa Supergenerics Ltd.
₹ 7.33
+1.81%
Haleos Labs Ltd.
₹ 1500.00
+2.39%
Advanced Enzyme Technologies Ltd.
₹ 302.20
+0.73%
Bajaj Healthcare Ltd.
₹ 322.00
+0.00%
Ortin Global Ltd.
₹ 15.26
-3.96%
Brooks Laboratories Ltd.
₹ 61.70
+2.83%
RPG Life Sciences Ltd.
₹ 2638.00
+0.05%
Bafna Pharmaceuticals Ltd.
₹ 254.55
+4.99%
Alpa Laboratories Ltd.
₹ 61.20
-2.47%
SMS Pharmaceuticals Ltd.
₹ 354.00
-0.73%
Nectar Lifesciences Ltd.
₹ 10.80
+3.15%
Mangalam Drugs and Organics Ltd.
₹ 30.44
+9.97%
Indoco Remedies Ltd.
₹ 220.00
-2.78%
Ind-Swift Laboratories Ltd.
₹ 325.35
-1.29%
Lincoln Pharmaceuticals Ltd.
₹ 612.00
-0.33%
Panacea Biotec Ltd.
₹ 406.50
-1.12%
Medicamen Biotech Ltd.
₹ 234.00
-4.31%
Themis Medicare Ltd.
₹ 120.50
+13.53%
By signing up I certify terms, conditions & privacy policy